Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.58 |
| ▸ | HTR2A | P28223 | 1/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.58 |
| ▸ | HTR2B | P41595 | 1/20 | 0.58 |
| ▸ | HTR3A | P46098 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | CASP6 | P55212 | 1/20 | 0.57 |
| ▸ | CD44 | P16070 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL9485632 | 0.94 | CYP1A2 (0.51) | CYP1A2CYP3A4ADRA2CHTR2AHTR2C | |
| Maleic Acid SCHEMBL9485625 | 0.94 | CYP1A2 (0.51) | CYP1A2CYP3A4ADRA2CHTR2AHTR2C | |
| SCHEMBL803 | 0.85 | KCNH2 (0.72) | CYP1A2CYP3A4ADRA2CHTR2AHTR2C | |
| Lurosetron SCHEMBL788289 | 0.85 | KCNH2 (0.72) | CYP1A2CYP3A4ADRA2CHTR2AHTR2C | |
| Lurosetron SCHEMBL30949356 | 0.85 | KCNH2 (0.72) | CYP1A2CYP3A4ADRA2CHTR2AHTR2C | |
| Lurosetron SCHEMBL7291773 | 0.84 | CASP6 (0.72) | CYP1A2CYP3A4ADRA2CHTR2AHTR2C | |
| Lurosetron SCHEMBL7336906 | 0.84 | KCNH2 (0.71) | CYP1A2CYP3A4ADRA2CHTR2AHTR2C | |
| SCHEMBL7291967 | 0.84 | CYP1A2 (0.56) | CYP1A2CYP3A4ADRA2CHTR2AHTR2C | |
| Lurosetron SCHEMBL635328 | 0.81 | KCNH2 (0.66) | CYP1A2CYP3A4ADRA2CHTR2AHTR2C | |
| Lurosetron SCHEMBL7336554 | 0.81 | KCNH2 (0.65) | CYP1A2CYP3A4ADRA2CHTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0353983-B1 | Lactam derivatives | GLAXO GROUP LTD (GB) | 1996-05-29 | — | — | EP | claimed |
| EP-0353983-A2 | Lactam derivatives | GLAXO GROUP LIMITED (GB) | 1990-02-07 | — | — | EP | claimed |
| EP-0353983-B1 | Lactam derivatives | GLAXO GROUP LTD (GB) | 1996-05-29 | — | — | EP | disclosed |
| US-5225407-A | Cognition activators | GLAXO GROUP LIMITED (GB) | 1993-07-06 | — | — | US | disclosed |
| US-5183820-A | Useful for treatment of nausea, vomiting, irritable bowel syndrome and dyspepsia | GLAXO GROUP LIMITED (GB) | 1993-02-02 | — | — | US | disclosed |
| EP-0450757-A2 | Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood | GLAXO GROUP LIMITED (GB) | 1991-10-09 | — | — | EP | disclosed |